Papers by Giampietro Viola
Cell Death & Differentiation, Jul 5, 2018
Glioblastoma multiforme (GBM) is a highly vascularized and aggressive brain tumor, with a strong ... more Glioblastoma multiforme (GBM) is a highly vascularized and aggressive brain tumor, with a strong ability to disseminate and invade the surrounding parenchyma. In addition, a subpopulation of GBM stem cells has been reported to possess the ability to transdifferentiate into tumor-derived endothelial cells (TDECs), supporting the resistance to anti-angiogenic treatments of newly formed blood vessels. Bone Morphogenetic Protein 9 (BMP9) is critically involved in the processes of cancer cell differentiation, invasion and metastasis, representing a potential tool in order to impair the intrinsic GBM aggressiveness. Here we demonstrate that BMP9 is able to trigger the activation of SMADs in patient-derived GBM cells, and to strongly inhibit proliferation and invasion by reducing the activation of PI3K/AKT/MAPK and RhoA/Cofilin pathways, respectively. Intriguingly, BMP9 treatment is sufficient to induce a strong differentiation of GBM stem-like cells and to significantly counteract the already reported process of GBM cell transdifferentiation into TDECs not only in in vitro mimicked TDEC models, but also in vivo in orthotopic xenografts in mice. Additionally, we describe a strong BMP9mediated inhibition of the whole angiogenic process engaged during GBM tumor formation. Based on these results, we believe that BMP9, by acting at multiple levels against GBM cell aggressiveness, can be considered a promising candidate, to be further developed, for the future therapeutic management of GBM.
Blood, Dec 6, 2014
The Forkhead box protein M1 (FOXM1) is a transcription factor that plays a central role in the re... more The Forkhead box protein M1 (FOXM1) is a transcription factor that plays a central role in the regulation of cell cycle, proliferation, DNA repair, and apoptosis. FOXM1 is overexpressed in many human tumors and its upregulation has been linked to high proliferation rates and poor prognosis. We therefore studied the role of FOXM1 in B-lymphoblastic leukemia (B-ALL) in order to understand whether FOXM1 could be a key target for leukemia therapy. RT-PCR and western blot analysis were carried out in a small cohort of pediatric BALL patients to evaluate FOXM1 levels. To assess its biological relevance, its expression was down-modulated by transient RNA interference in BALL cell lines (REH and NALM-6). Our results show that FOXM1 expression is higher in both BALL patients and cell lines when compared to PBMC or normal B-cells (CD19 +) from healthy donors. Furthermore, blocking FOXM1 activity in two BALL cell lines, by either knockdown or treatment with the FOXM1 inhibitor thiostrepton, causes significant decrease in their cell proliferation. This decrease in cell proliferation was coupled with both an induction of the G2/M cell cycle arrest and with a reduction in the S phase population. Finally, we noted how thiostrepton synergises with chemotherapeutic agents commonly used in BALL therapy, thus increasing their efficiency. Therefore our results suggest that FOXM1 is highly expressed in both patients and BALL cell lines, and that targeting FOXM1 could be an attractive strategy for leukemia therapy and for overcoming drug resistance.
Organic and Biomolecular Chemistry, 2021
A series of ten 2,7-and 2,8-diarylquinolizinium derivatives was synthesized and their DNA-binding... more A series of ten 2,7-and 2,8-diarylquinolizinium derivatives was synthesized and their DNA-binding and cytotoxic properties were investigated. Except for one nitro-substituted derivative all tested diarylquinolizinium ions bind to DNA with sufficient affinity (2 × 10 4 M −1-2 × 10 5 M −1). It was shown with photometric, fluorimetric and polarimetric titrations as well as with flow-LD analysis that the ligands bind mainly by intercalation to duplex DNA, however, depending on the ligand-DNA ratio, groove binding and backbone association were also observed with some derivatives. The biological activity was further investigated with tests of cytotoxicity and antiproliferative properties towards non-tumor cells and selected cancer cells, along with cell cycle analysis and an annexin-V assay. Notably, substrates that carry donor-functionalities in the 4-position of the phenyl substituents revealed a strong, and in some cases selective, antiproliferative activity as quantified by the growth inhibition, GI 50 , at very low micromolar and even submicromolar level both in leukemia and solid tumors. † Electronic supplementary information (ESI) available: Experimental procedures, additional spectroscopic data, 1 H and 13 C NMR spectra. See
Pharmaceutics, Jun 2, 2022
This article is an open access article distributed under the terms and conditions of the Creative... more This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY
Biosensors, Oct 13, 2021
This article is an open access article distributed under the terms and conditions of the Creative... more This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY
Farmaco, Apr 1, 2000
The non-covalent interaction of a series of new water-soluble benzo- and tetrahydrobenzofurocouma... more The non-covalent interaction of a series of new water-soluble benzo- and tetrahydrobenzofurocoumarins with salmon testes DNA has been studied using flow linear dichroism, circular dichroism, contact fluorescence energy transfer and ethidium bromide displacement assay. The new derivatives are characterised by having an alkyl amino side chain protonated at physiological pH; this fact strongly enhances the solubility in aqueous media and the affinity for the macromolecule. The results show significant difference in the affinity and the mode of binding among the examined compounds depending on the nature of the fourth condensed ring and the position of the alkylamino side chain. Benzofurocoumarins derivatives bind DNA by undergoing intercalation inside the duplex macromolecule, whereas tetrahydrobenzofurocoumarins derivatives show a substantial tilt relative to the base planes. Molecular modeling studies have been performed to characterise in detail the intercalation mechanism of these benzofurocoumarins to DNA.
Beilstein Journal of Organic Chemistry, May 2, 2016
Cationic biaryl derivatives were synthesized by Suzuki-Miyaura coupling of 3-bromonaphtho[1,2-b]q... more Cationic biaryl derivatives were synthesized by Suzuki-Miyaura coupling of 3-bromonaphtho[1,2-b]quinolizinium bromide with arylboronic acids. The resulting cationic biaryl derivatives exhibit pronounced fluorosolvatochromic properties. First photophysical studies in different solvents showed that the emission energy of the biaryl derivatives decreases with increasing solvent polarity. This red-shifted emission in polar solvents is explained by a charge shift (CS) in the excited state and subsequent solvent relaxation. Furthermore, the polarity of protic polar and aprotic polar solvents affects the emission energy to different extent, which indicates a major influence of hydrogen bonding on the stabilization of the ground and excited states.
European Journal of Medicinal Chemistry, 2019
British Journal of Cancer, Mar 8, 2018
BACKGROUND: Despite chemotherapy intensification, a subgroup of high-risk paediatric T-cell acute... more BACKGROUND: Despite chemotherapy intensification, a subgroup of high-risk paediatric T-cell acute lymphoblastic leukemia (T-ALL) patients still experience treatment failure. In this context, we hypothesised that therapy resistance in TALL might involve aldoketo reductase 1C (AKR1C) enzymes as previously reported for solid tumors. METHODS: Expression of NRF2-AKR1C signaling components has been analysed in paediatric TALL samples endowed with different treatment outcomes as well as in patient-derived xenografts of TALL. The effects of AKR1C enzyme modulation has been investigated in TALL cell lines and primary cultures by combining AKR1C inhibition, overexpression, and gene silencing approaches. RESULTS: We show that TALL cells overexpress AKR1C1-3 enzymes in therapy-resistant patients. We report that AKR1C1-3 enzymes play a role in the response to vincristine (VCR) treatment, also ex vivo in patient-derived xenografts. Moreover, we demonstrate that the modulation of AKR1C1-3 levels is sufficient to sensitise TALL cells to VCR. Finally, we show that TALL chemotherapeutics induce overactivation of AKR1C enzymes independent of therapy resistance, thus establishing a potential resistance loop during TALL combination treatment. CONCLUSIONS: Here, we demonstrate that expression and activity of AKR1C enzymes correlate with response to chemotherapeutics in TALL , posing AKR1C1-3 as potential targets for combination treatments during TALL therapy.
Bioorganic & Medicinal Chemistry, Jun 1, 2014
In this study, we synthesized a series of trans-indole-3-acrylamide derivatives (3a-k) and invest... more In this study, we synthesized a series of trans-indole-3-acrylamide derivatives (3a-k) and investigated their activity for inhibition of cell proliferation against five human cancer cell lines (HeLa, MCF7, MDA-MB-231, Raji and HL-60) by MTT assay. Compound 3e showed significant antiproliferative activity against both the Raji and HL-60 cell lines with IC 50 values of 9.5 and 5.1 µM, respectively. Compound 3e also exhibited moderate inhibitory activity on tubulin polymerization (IC 50 = 17 µM). Flow cytometric analysis of cultured cells treated with 3e also demonstrated that the compound caused cell cycle arrest at the G2/M phase in HL-60 and HeLa cells. Moreover, 3e, the most active compound, caused an apoptotic cell death through the activation of caspase-3. Docking simulations suggested that 3e binds to the colchicine site of tubulin.
European journal of medicinal chemistry, Aug 1, 2014
A novel series of imidazo[2,1-b]thiazole-sulfonyl piperazine conjugates (9aa-ee) has been synthes... more A novel series of imidazo[2,1-b]thiazole-sulfonyl piperazine conjugates (9aa-ee) has been synthesized and evaluated for carbonic anhydrase (CA, EC 4.2.1.1) inhibitory potency against four isoforms: The cytosolic isozyme hCA I, II and trans-membrane tumor-associated isoform hCA IX and hCA XII, taking acetazolamide (AAZ) as standard drug, using a stopped flow CO 2 hydrase assay. The results revealed that most of the compounds showed selective activity against hCA II whereas none of them were active against hCA I, IX, XII (K i > 100 µM). The physiologically dominant cytosolic isoform hCA II was inhibited by these molecules with inhibition constants in the range of 57.7-98.2 µM. This new derivative, thus, selectively inhibits hCA II over the hCA I, IX, XII isoforms, which may be used for further understanding the physiological roles of some of these isoforms in various pathologies.
Journal of Medicinal Chemistry, Jan 11, 2019
El e n a , M a t ti uzzo, El e n a a n d Viol a, Gi a m pi e t r o 2 0 1 9. D e si g n, sy n t h ... more El e n a , M a t ti uzzo, El e n a a n d Viol a, Gi a m pi e t r o 2 0 1 9. D e si g n, sy n t h e sis, a n d biolo gic al ev al u a tio n of 6-S u b s ti t u t e d Thi e n o[ 3, 2-d] py ri mi di n e a n alo g u e s a s d u al e pi d e r m al g r o w t h fa c t o r r e c e p t o r ki n a s e a n d m i c r o t u b ul e in hi bit o r s. Jou r n al of M e di ci n al C h e mi s t ry 6 2 (3) , p p. 1 2 7 4-1 2 9 0.
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry
Hematological cancers are among the most common cancers in adults and in children. Despite signif... more Hematological cancers are among the most common cancers in adults and in children. Despite significant improvements in therapies, many patients still succumb to the disease, therefore, novel therapies are needed. The Wiskott-Aldrich syndrome protein (WASp) family proteins regulate actin assembly in conjunction with the Arp2/3 complex, a ubiquitous nucleation factor. WASp is expressed exclusively in hematopoietic cells and exists in two allosteric conformations, auto-inhibited and active conformations. Here, we describe the development of EG-011, a first-in-class small molecule activator of the WASp auto-inhibited form. EG-011 possesses in vitro and in vivo anti-tumor activity as single agent in lymphoma, leukemia and multiple myeloma, including models of secondary resistance to PI3K, BTK and proteasome inhibitors. The in vitro activity was confirmed in a lymphoma xenograft. Actin polymerization induced by EG-011 was demonstrated with multiple techniques. Transcriptome analysis highl...
Neuro-Oncology
Medulloblastoma (MB) is the deadliest brain tumor of childhood, intrinsically characterized by fa... more Medulloblastoma (MB) is the deadliest brain tumor of childhood, intrinsically characterized by fast growth, high invasiveness, and resistance to treatments. With the aim to deepen the molecular basis of MB aggressiveness and recurrence, we established an in vitro model of MB resistance to chemotherapy, in which, a weekly exposure to a cocktail of chemotherapeutics commonly used in MB treatment (Vincristine, Etoposide, Cisplatin, Cyclophosphamide – VECC) induces the selection of cells that progressively acquire resistance to subsequent VECC treatments. Preliminary data on our model of MB resistance show that resistant cells induce the activation of the two main regulator of pentose phosphate pathway TKT and G6PD via the activation of Nrf2 transcriptional activity. Moreover, resistant cells show an increase in hypoxia inducible factor-1α (HIF-1α) together with an augmented expression of glycolytic enzymes HK1, PFKB-3, PDK1 and LDHA and increased glycolytic capacity. Interestingly, enr...
Uploads
Papers by Giampietro Viola